Forbion closes second FCF 1 Co-Investment Fund at $50m

The fund targets portfolio companies of existing funds that are close to exit or require additional capital.

The oversubscribed vehicle has a shorter-than-standard lifespan, due to the time sensitive investment in companies near to exit.

Fees, carry and hurdle were not disclosed but are expected to be market standard.

The first FCF 1 Co-Investment Fund closed on €54m in September 2010. Forbion has sourced six investments from that fund. Of the portfolio, Biovex and Pathway Medical have already been sold for a total consideration of $1.125bn and repaid the entire fund by almost double the amount.

Investors
Due to good performance of the assets in the first FCF 1 Co-Investment Fund, all LPs have re-invested in the second fund. They are professional investors and funds-of-funds based in Europe and the US. 

Investments
The first investment from the new fund was been made in Circulite in November 2011. 

People
Sander Slootweg worked on the fund for Forbion. 

Advisers
Loyens & Loeff (Legal).
 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Benelux
• Netherlands